Trial Profile

A Phase 3, Randomized, Placebo-controlled, Double Blind Study of KW-3357 in Patients With Early Onset Severe Preeclampsia

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 17 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Antithrombin gamma (Primary)
Indications Preeclampsia
Focus Registrational; Therapeutic Use
Acronyms KOUNO-TORI
Sponsors Kyowa Kirin

Most Recent Events

28 Sep 2023 Primary endpoint has not been met. (Days of maintaining pregnancy), according to a Kyowa Kirin Media Release.
28 Sep 2023 Results presented in the Kyowa Kirin Media Release.
13 Jul 2023 Inclusion criteria is updated to decreased the minimum age limit from 20 years to 18 years.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com